Joseph P Hagan - Net Worth and Insider Trading
Joseph P Hagan Net Worth
The estimated net worth of Joseph P Hagan is at least $202,318 dollars as of 2024-12-14. Joseph P Hagan is the Director of Aurinia Pharmaceuticals Inc and owns about 11,961 shares of Aurinia Pharmaceuticals Inc (AUPH) stock worth over $112,075. Joseph P Hagan is the CEO of Regulus Therapeutics Inc and owns about 57,112 shares of Regulus Therapeutics Inc (RGLS) stock worth over $90,237. Joseph P Hagan is also the Sr. VP, Corporate Development of Orexigen Therapeutics Inc and owns about 1,303 shares of Orexigen Therapeutics Inc (OREXQ) stock worth over $7. Details can be seen in Joseph P Hagan's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Joseph P Hagan has not made any transactions after 2024-01-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Joseph P Hagan
Joseph P Hagan Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Joseph P Hagan owns 4 companies in total, including Regulus Therapeutics Inc (RGLS) , Zosano Pharma Corp (ZSANQ) , and Orexigen Therapeutics Inc (OREXQ) among others .
Click here to see the complete history of Joseph P Hagan’s form 4 insider trades.
Insider Ownership Summary of Joseph P Hagan
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| RGLS | Regulus Therapeutics Inc | 2024-01-18 | Chief Operating Officer |
| ZSANQ | Zosano Pharma Corp | 2020-06-25 | director |
| OREXQ | Orexigen Therapeutics Inc | 2015-02-03 | Chief Business Officer |
 | | 2023-05-19 | director |
Joseph P Hagan Latest Holdings Summary
Joseph P Hagan currently owns a total of 3 stocks. Among these stocks, Joseph P Hagan owns 11,961 shares of Aurinia Pharmaceuticals Inc (AUPH) as of May 19, 2023, with a value of $112,075 and a weighting of 55.4%. Joseph P Hagan owns 57,112 shares of Regulus Therapeutics Inc (RGLS) as of January 18, 2024, with a value of $90,237 and a weighting of 44.6%. Joseph P Hagan also owns 1,303 shares of Orexigen Therapeutics Inc (OREXQ) as of September 15, 2014, with a value of $7 and a weighting of 0%.
Latest Holdings of Joseph P Hagan
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AUPH | Aurinia Pharmaceuticals Inc | 2023-05-19 | 11,961 | 9.37 | 112,075 |
| RGLS | Regulus Therapeutics Inc | 2024-01-18 | 57,112 | 1.58 | 90,237 |
| OREXQ | Orexigen Therapeutics Inc | 2014-09-15 | 1,303 | 0.01 | 7 |
Holding Weightings of Joseph P Hagan
Joseph P Hagan Form 4 Trading Tracker
According to the SEC Form 4 filings, Joseph P Hagan has made a total of 1 transactions in Aurinia Pharmaceuticals Inc (AUPH) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Aurinia Pharmaceuticals Inc is the sale of 272 shares on May 19, 2023, which brought Joseph P Hagan around $2,878.
According to the SEC Form 4 filings, Joseph P Hagan has made a total of 8 transactions in Regulus Therapeutics Inc (RGLS) over the past 5 years, including 1 buys and 7 sells. The most-recent trade in Regulus Therapeutics Inc is the sale of 14,580 shares on January 18, 2024, which brought Joseph P Hagan around $17,350.
According to the SEC Form 4 filings, Joseph P Hagan has made a total of 0 transactions in Orexigen Therapeutics Inc (OREXQ) over the past 5 years. The most-recent trade in Orexigen Therapeutics Inc is the acquisition of 500 shares on September 15, 2014, which cost Joseph P Hagan around $23,450.
Insider Trading History of Joseph P Hagan
- 1
Joseph P Hagan Trading Performance
GuruFocus tracks the stock performance after each of Joseph P Hagan's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Joseph P Hagan is -7.64%. GuruFocus also compares Joseph P Hagan's trading performance to market benchmark return within the same time period. The performance of stocks bought by Joseph P Hagan within 3 months outperforms 3 times out of 5 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Joseph P Hagan's insider trading performs compared to the benchmark.
Performance of Joseph P Hagan
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -10.78 | | | | | |
| Relative Return to S&P 500(%) | -10.16 | | | | | |
Joseph P Hagan Ownership Network
Ownership Network List of Joseph P Hagan
Ownership Network Relation of Joseph P Hagan
Joseph P Hagan Owned Company Details
What does Regulus Therapeutics Inc do?
Who are the key executives at Regulus Therapeutics Inc?
Joseph P Hagan is the Chief Operating Officer of Regulus Therapeutics Inc. Other key executives at Regulus Therapeutics Inc include Chief Financial Officer Crispina Calsada , Sr. VP & General Counsel Christopher Ray Aker , and President & Head of R & D Preston Klassen .
Regulus Therapeutics Inc (RGLS) Insider Trades Summary
Over the past 18 months, Joseph P Hagan made 1 insider transaction in Regulus Therapeutics Inc (RGLS) with a net sale of 14,580. Other recent insider transactions involving Regulus Therapeutics Inc (RGLS) include a net sale of 5,468 shares made by Christopher Ray Aker , a net sale of 5,468 shares made by Crispina Calsada , and a net purchase of 4,000 shares made by Kathryn J Collier .
In summary, during the past 3 months, insiders sold 0 shares of Regulus Therapeutics Inc (RGLS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 25,516 shares of Regulus Therapeutics Inc (RGLS) were sold and 4,000 shares were bought by its insiders, resulting in a net sale of 21,516 shares.
Regulus Therapeutics Inc (RGLS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Regulus Therapeutics Inc Insider Transactions
Joseph P Hagan Mailing Address
Above is the net worth, insider trading, and ownership report for Joseph P Hagan. You might contact Joseph P Hagan via mailing address: 3344 N. Torrey Pines Court, Suite 200, La Jolla Ca 92037.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
